Table 3.

Evaluation of Surrogate Virus Neutralization assay against the WT strain using the population cut-off vs the manufacturer’s cut-off value.

WT cutoff value, CI
Diagnostic metrics27.69%30.0%DifferenceTest statisticsP-value
Sensitivity100.0% (96.9%–100%)91.4% (84.7%–95.8%)−8.610.00.002
Specificity66.7% (9.4%–99.2%)66.7% (9.4%–99.2%)0.0NANA
PPV99.1% (95.3%–100%)99.1% (94.9%–100%)0.999−0.953.340
NPV100.0% (15.8%–100%)16.7% (2.1%–48.4%)0.167−2.776.006
WT cutoff value, CI
Diagnostic metrics27.69%30.0%DifferenceTest statisticsP-value
Sensitivity100.0% (96.9%–100%)91.4% (84.7%–95.8%)−8.610.00.002
Specificity66.7% (9.4%–99.2%)66.7% (9.4%–99.2%)0.0NANA
PPV99.1% (95.3%–100%)99.1% (94.9%–100%)0.999−0.953.340
NPV100.0% (15.8%–100%)16.7% (2.1%–48.4%)0.167−2.776.006

PPV: Positive predictive value, NPV: Negative predictive value, NA: Not applicable.

Table 3.

Evaluation of Surrogate Virus Neutralization assay against the WT strain using the population cut-off vs the manufacturer’s cut-off value.

WT cutoff value, CI
Diagnostic metrics27.69%30.0%DifferenceTest statisticsP-value
Sensitivity100.0% (96.9%–100%)91.4% (84.7%–95.8%)−8.610.00.002
Specificity66.7% (9.4%–99.2%)66.7% (9.4%–99.2%)0.0NANA
PPV99.1% (95.3%–100%)99.1% (94.9%–100%)0.999−0.953.340
NPV100.0% (15.8%–100%)16.7% (2.1%–48.4%)0.167−2.776.006
WT cutoff value, CI
Diagnostic metrics27.69%30.0%DifferenceTest statisticsP-value
Sensitivity100.0% (96.9%–100%)91.4% (84.7%–95.8%)−8.610.00.002
Specificity66.7% (9.4%–99.2%)66.7% (9.4%–99.2%)0.0NANA
PPV99.1% (95.3%–100%)99.1% (94.9%–100%)0.999−0.953.340
NPV100.0% (15.8%–100%)16.7% (2.1%–48.4%)0.167−2.776.006

PPV: Positive predictive value, NPV: Negative predictive value, NA: Not applicable.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close